Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Treatment of Diffuse Hyperpigmentation
Description
In this lecture, Dr. Raheel Zubair discusses the treatment of diffuse hyperpigmentation, highlighting its significance due to the distress it causes patients, particularly those with drug-induced pigmentation. He emphasizes the need for early diagnosis and accurate evaluation of hyperpigmentation, which can stem from various medical conditions like adrenal and pituitary diseases, and effects from drugs like ibuprofen or minocycline. Several cases illustrate the challenges and potential treatments, including the use of picosecond lasers, which provide effective options with shorter pulse durations that minimize the risk of post-inflammatory hyperpigmentation. The importance of customized treatment strategies based on individual patient factors, skin types, and the specific pigmentation conditions is underscored throughout the presentation. For instance, patients with hemosiderin staining post-sclerotherapy may require specific laser treatments for effective results. Overall, a thorough understanding of the pathology behind the various types of hyperpigmentation and tailored laser treatment approaches are essential for successful patient outcomes.
View moreConclusions
- Early diagnosis of diffuse hyperpigmentation is crucial due to its potential severity and patient distress.
- Differentiation between types of hyperpigmentation is necessary for effective treatment strategies.
- Drug-induced hyperpigmentation can be particularly distressing due to its unnatural appearance and persistence.
- Laser treatments, especially using shorter pulse durations like picosecond lasers, are effective for various types of hyperpigmentation.
- Picosecond lasers offer advantages in minimizing risk of post-inflammatory hyperpigmentation and enhancing treatment efficacy.
- Different types of hyperpigmentation may require tailored laser treatments depending on the chromophore and depth involved.
- Selected cases demonstrate significant improvement after multiple treatments with specific laser modalities.
- Bolognia, Jean L., et al. Dermatology. Elsevier Mosby, 2008. Chapter 67 Disorders of Hyperpigmentation.
- Watchmaker, Jacqueline, and Prasanthi Kandula. "Hyperpigmentation From Fixed Drug Eruption Successfully Treated With a Low-Fluence 1064 Nm Nd:YAG Picosecond Laser." Dermatologic Surgery 47, no. 11 (November 2021): 1529.
- Zhao, Fang, Yan Li, and Zudong Meng. "Successful Treatment of Hyperpigmentation from Fixed Drug Eruption with a Low-Dose and Large-Spot Q-Switched 1064 Nm Nd:YAG Laser." Journal of Cosmetic Dermatology 22, no. 7 (2023): 2128-30.
- DiGiorgio, Catherine M. MS, MD; Wu, Douglas C. MD, DPhil; Goldman, Mitchel P. MD, FAAD. "Successful Treatment of Argyria Using the Picosecond Alexandrite Laser." Dermatologic Surgery 42(3):p 431-433, March 2016.
- Yildiz, Abdullah. "Ochronosis - Case." Journal of Laser and Health Academy 2017 Clinical Bulletin. Turkey.
- Almeida Filippo, Alexandre de, Abdo Salomão Júnior, Paulo Santos Torreão, Lilian Mathias Delorenze, and Maria Claudia Almeida Issa. "Erbium Laser for Photorejuvenation." In Lasers, Lights and Other Technologies, edited by Maria Claudia Almeida Issa and Bhertha Tamura, 1-11. Clinical Approaches and Procedures in Cosmetic Dermatology. Cham: Springer International Publishing, 2017.
- Alajmi, Ali, Ghassan Niaz, Kachiu Lee, and Eric F. Bernstein. "Treatment of Minocycline-Induced Hyperpigmentation with 730 Nm Ti:Sapphire Picosecond Laser." JAAD Case Reports 43 (January 1, 2024): 62-68.
- Goo, Boncheol Leo, and Sung Bin Cho. "Efficacy and Safety of Picosecond-Domain Neodymium-Doped Yttrium Aluminum Garnet Laser Treatment on Various Causes of Traumatic Tattoos." Medical Lasers 5, no. 2 (December 30, 2016): 90-95.
- Star, Phoebe, Carolyn Choy, and Kurosh Parsi. "Black Veins: A Case of Minocycline-Induced Pigmentation Post-Sclerotherapy and a Review of Literature." Journal of Cutaneous Pathology 44, no. 1 (2017): 83-92.